European Leukemia Trial Registry
Trial: AMLSG 18-12

More Details
Short Title AMLSG 18-12
Trialgroup AMLSG Ulm
Type of Trial NIS, multicentric, single-group, prospective, open-label
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status No longer recruiting
Start of Recruitment 01.02.2013
Leader Greiner, Prof., Jochen

Study Centre
Rudolph, Christiane
Tel: +49 (0)731 500 45903
Fax: +49 (0)731 500 45905

Centre of Trial Universitätsklinikum Ulm
Shortprotocol Shortprotocol

Labor für Zytogenetische und Molekulargenetische Diagnostik, Klinik für Innere Med. III, Universitätsklinikum Ulm

created 13.02.2013 Johannes Kraus
changed 09.04.2018 Martina Wolkenfeld
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |